Tubularized incised plate urethroplasty for proximal hypospadias.

A modified tubularised incised plate urethroplasty technique and a revised hypospadias algorithm. Indian J Plast Surg (2010) 1.36

Learning curve for TIP urethroplasty: A single-surgeon experience. Can Urol Assoc J (2014) 1.23

Tubularized incised plate urethroplasty for distal hypospadias: A literature review. Indian J Urol (2008) 1.14

Urethroplasty by use of turnover flaps (modified mathieu procedure) for distal hypospadias repair in adolescents: comparison with the tubularized incised plate procedure. Korean J Urol (2014) 0.83

Penile block is associated with less urinary retention than caudal anesthesia in distal hypospadia repair in children. World J Urol (2009) 0.81

Comparison of transverse island flap onlay and tubularized incised-plate urethroplasties for primary proximal hypospadias: a systematic review and meta-analysis. PLoS One (2014) 0.81

Single vs. double dartos layers for preventing fistula in a tubularised incised-plate repair of distal hypospadias. Arab J Urol (2012) 0.77

Short-term catheterization after TIP repair in distal hypospadias: who are the best candidates? Pediatr Surg Int (2006) 0.76

Complications of hypospadias surgery: Experience in a tertiary hospital of a developing country. Afr J Paediatr Surg (2015) 0.75

Combined Use of the Mathieu and Incised Urethral Plate Techniques for Repair of Distal Penile Hypospadias. Indian J Surg (2013) 0.75

Intermediate-term functional and cosmetic results of the Snodgrass procedure in distal and midpenile hypospadias. Pediatr Surg Int (2004) 0.75

Modified tubularized incised plate urethroplasty reduces the risk of fistula and meatal stenosis for proximal hypospadias: a report of 63 cases. Int Urol Nephrol (2017) 0.75

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06

Mechanisms of epithelial cell-cell adhesion and cell compaction revealed by high-resolution tracking of E-cadherin-green fluorescent protein. J Cell Biol (1998) 5.03

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65

Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med (2001) 3.60

Glycogen storage disease in adults. Ann Intern Med (1994) 3.58

New paths in human cancer serology. J Exp Med (1998) 3.12

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr (2006) 2.97

RNA dependent DNA polymerase of human acute leukaemic cells. Nature (1970) 2.96

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer (2001) 2.95

Occluded and nonoccluded nuclear polyhedrosis virus grown in Trichoplusia ni: comparative neutralization comparative infectivity, and in vitro growth studies. J Virol (1976) 2.90

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A (2000) 2.79

Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J (2000) 2.71

Factors affecting synthesis of ascorbic acid in cress seedlings. 2. Ascorbic acid synthesis in relation to sugar formation. Biochem J (1949) 2.46

Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc (2000) 2.35

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer (1999) 2.26

Microstructural fingerprints of phase transitions in shock-loaded iron. Sci Rep (2013) 2.17

Reliability of reported sunburn history in a case-control study of cutaneous malignant melanoma. Am J Epidemiol (1995) 2.05

Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1987) 2.05

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A (2000) 2.02

Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res (2000) 1.95

Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer (1999) 1.91

Polymorphism in sulfonamides. J Pharm Sci (1972) 1.89

Cornstarch therapy in type I glycogen-storage disease. N Engl J Med (1984) 1.88

Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. Mol Ther (2005) 1.87

A mouse mutant p53 product recognized by CD4+ and CD8+ T cells. Proc Natl Acad Sci U S A (1994) 1.86

Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol (2001) 1.83

Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer (1998) 1.82

Isolation of averufin from a mutant of Aspergillus parasiticus impaired in aflatoxin biosynthesis. Biochem Biophys Res Commun (1972) 1.82

Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab (2002) 1.82

Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol (2000) 1.81

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol (2000) 1.76

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci U S A (1995) 1.75

A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med (1999) 1.74

Structure-based mutagenesis reveals distinct functions for Ras switch 1 and switch 2 in Sos-catalyzed guanine nucleotide exchange. J Biol Chem (2001) 1.71

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer (2001) 1.71

Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun (2001) 1.69

Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation (1999) 1.69

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med (2000) 1.67

Quality of care for patients hospitalized with heart failure at academic medical centers. Am Heart J (1999) 1.65

Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5' flanking region. Genomics (1996) 1.63

Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol Cell Biol (1996) 1.63

Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol (2006) 1.62

Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer (2000) 1.60

SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer (1997) 1.60

Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells. Cell (1984) 1.57

Analysis of high-molecular-weight ribonucleic acid associated with intracisternal A particles. J Virol (1973) 1.55

Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol (1998) 1.55

Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet (1993) 1.52

A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol (1998) 1.51

Lack of evidence for an association between alpha-adducin and blood pressure regulation in Asian populations. Am J Hypertens (2000) 1.51

Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol (1998) 1.50

Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry (2010) 1.49

Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction. Arch Intern Med (2001) 1.48

Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care (1999) 1.47

Regulation of Sos activity by intramolecular interactions. Mol Cell Biol (1998) 1.46

Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A (1999) 1.46

Reverse transcriptase, RNA tumour virus transformation and derivatives of rifamycin SV. Nat New Biol (1972) 1.44

Improved fluorescence and dual color detection with enhanced blue and green variants of the green fluorescent protein. J Biol Chem (1998) 1.43

The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42

CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer (2000) 1.42

Structural analysis of TL genes of the mouse. Proc Natl Acad Sci U S A (1985) 1.41

Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin. J Cell Biol (1998) 1.40

Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest (1996) 1.40

Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res (2001) 1.39

Report of fourteen cases of nonimmune hydrops fetalis in association with hemorrhagic endovasculitis of the placenta. Am J Obstet Gynecol (1991) 1.39

Glycogen storage disease types I and II: treatment updates. J Inherit Metab Dis (2007) 1.39

Brain abscess in glycogen storage disease type Ib. Acta Paediatr Scand (1991) 1.38

Iron-molybdenum cofactor from nitrogenase. Modified extraction methods as probes for composition. J Biol Chem (1982) 1.37

Characterization of an endogenous RNA-dependent DNA polymerase associated with murine intracisternal A particles. J Virol (1974) 1.36

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci U S A (2000) 1.36

Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35

Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest (1998) 1.34

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer (2000) 1.34

Nitrogen fixation in Klebsiella pneumoniae during osmotic stress. Effect of exogenous proline or a proline overproducing plasmid. Biochim Biophys Acta (1982) 1.33

Cloning of the debranching-enzyme gene from Thermoanaerobium brockii into Escherichia coli and Bacillus subtilis. J Bacteriol (1987) 1.31

Short rib-polydactyly syndrome, Majewski type. Am J Med Genet (1980) 1.31

Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr (1999) 1.30

Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett (2000) 1.30

A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet (1998) 1.28

Preservation of the thin distal urethra in hypospadias repair. J Urol (2000) 1.27

Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res (1998) 1.27

Thanatophoric dysplasia and cloverleaf skull. Am J Med Genet Suppl (1987) 1.26

Purification of acetylcholinesterase by affinity chromatography and determination of active site stoichiometry. J Biol Chem (1972) 1.26

The incidence of coronary artery disease in patients with symptomatic bradyarrhythmias. Jpn Heart J (2001) 1.25

Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med (1992) 1.25

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer (1998) 1.25

Expression of SSX genes in human tumors. Int J Cancer (1998) 1.24

Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest (1996) 1.24

Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer Res (2000) 1.23

Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics (1992) 1.22

Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr (1990) 1.22

Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. J Inherit Metab Dis (2000) 1.22

Left ventricular abnormalities in prolapsed mitral leaflet syndrome. Review of eighty-seven cases. Circulation (1973) 1.22

Inhibition of hydroxymethylglutaryl-coenzyme A synthase by L-659,699. Proc Natl Acad Sci U S A (1987) 1.21

R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese. J Med Genet (2005) 1.21

Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. J Clin Invest (1995) 1.20

High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc Natl Acad Sci U S A (1996) 1.18